No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Market Participants Recognise Prenetics Global Limited's (NASDAQ:PRE) Revenues Pushing Shares 28% Higher
Express News | Prenetics’ IM8 Announces Collaboration With Mayo Clinic to Develop New Line of Premium Supplements
Prenetics' IM8 Announces Collaboration With Mayo Clinic to Develop New Line of Premium Supplements
Prenetics Global Announces 2024 Annual General Meeting
IAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024
Prenetics' IM8 And University Of Oxford Launch Space Experiment On ISS To Study Accelerated Aging And Longevity
No Data